WallStSmart
IMNN

Imunon Inc

NASDAQ: IMNN · HEALTHCARE · BIOTECHNOLOGY

$2.83
+5.60% today

Updated 2026-04-30

Market cap
$10.98M
P/E ratio
P/S ratio
17.94x
EPS (TTM)
$-6.83
Dividend yield
52W range
$3 – $36
Volume
0.1M

Imunon Inc (IMNN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-7.23M$-9.58M$2.28M$-930331.00$-13.37M$-22.74M$-22.14M$-9.53M$-21.35M$-20.83M$-18.38M$-16.64M$-7.04M$-20.26M$-15.62M$-16.22M$-23.10M$-19.02M$-18.85M$-13.90M
Capital expenditures$262817.00$1.69M$24225.00$136223.00$6745.00$573406.00$613390.00$57494.00$672256.00$109341.00$62503.00$38629.00$138399.00$349158.00$19092.00$311613.00$267800.00$451759.00$29541.00$280572.00
Depreciation
Stock-based comp$1.07M$861489.00$1.09M$1.65M$1.21M$1.14M$1.24M$2.59M$1.85M$1.51M$1.11M$4.60M$2.29M$1.85M$3.76M$2.67M$759013.00$477256.00$127374.00
Free cash flow$-7.50M$-11.27M$2.26M$-1.07M$-13.37M$-23.32M$-22.76M$-9.58M$-22.03M$-20.94M$-18.44M$-16.68M$-7.18M$-20.61M$-15.64M$-16.54M$-23.36M$-19.47M$-18.88M$-14.18M
Investing cash flow
Financing cash flow
Dividends paid$0.00$10277.00
Share repurchases
Debt repayment
Net change in cash